Showing results (351-360 of 531) with videos related to

Sort By:
Pageof 54
Endoscopic Surgery and Allied Technologies|February 1, 1994
Analysis of surgical movements during suturing in laparoscopyZ Szabo, J Hunter, G Berci, et al.
The American Journal of Cardiology|December 15, 1995
Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery diseaseC S Barr, C C Lang, J Hanson, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 4, 2011
The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trialM D Witham, F J Dove, J A Sugden, et al.
Clinical Science (London, England : 1979)|August 1, 1992
Effect of angiotensin-converting enzyme inhibition on plasma brain natriuretic peptide levels in patients with heart failureC C Lang, J G Motwani, A R Rahman, et al.
Journal of Hypertension|July 1, 1993
The effect of intravenous saline loading on plasma levels of brain natriuretic peptide in manC C Lang, A M Choy, K Turner, et al.
Heart (British Cardiac Society)|June 23, 1999
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?R J MacFadyen, A F Lee, J J Morton, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1987
The interaction between noradrenaline and angiotensin II in man: evidence for a postsynaptic and against a presynaptic interactionP H Seidelin, W J Coutie, M S Pai, et al.
European Heart Journal|December 24, 1997
Right coronary artery stenosis is associated with impaired cardiac endocrine function during exerciseN C Davidson, S D Pringle, T H Pringle, et al.
BMJ (Clinical Research Ed.)|April 6, 1996
Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular diseaseD Darbar, J Luck, N Davidson, et al.
Clinical Pharmacology and Therapeutics|December 1, 1993
Dose-ranging effects of candoxatril on elimination of exogenous atrial natriuretic peptide in chronic heart failureJ G Motwani, C C Lang, M J Allen, et al.
Pageof 54